ProQuest Investments IV, L.P., 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 22,100 shares at $70.06 ($1.5M) on 2016-09-30, disclosed to the SEC on 2016-10-04.
Open-market sale of $1.5M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| EGRX | SELL | 2016-09-23 | $13.2M | — | Filing → |
| EGRX | SELL | 2016-08-25 | $1.8M | — | Filing → |
| EGRX | SELL | 2016-08-17 | $6.1M | — | Filing → |